| scholarly article | Q13442814 |
| P50 | author | Bengt Glimelius | Q30830855 |
| P2093 | author name string | L Påhlman | |
| K Smedh | |||
| U Gunnarsson | |||
| C Tiselius | |||
| P2860 | cites work | An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. | Q31106341 |
| Effective surgical adjuvant therapy for high-risk rectal carcinoma | Q33387384 | ||
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| A systematic overview of chemotherapy effects in colorectal cancer | Q34301222 | ||
| Chemotherapy with preoperative radiotherapy in rectal cancer | Q34570877 | ||
| Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer | Q34571028 | ||
| Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. | Q34571372 | ||
| Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. | Q34579124 | ||
| Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
| Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. | Q34725978 | ||
| Results of radical surgery for rectal cancer | Q35588274 | ||
| Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. | Q37158196 | ||
| Evolution of nonsurgical therapy for colorectal cancer | Q37372475 | ||
| Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. | Q37412279 | ||
| Rectal cancer radiotherapy: towards European consensus | Q37789029 | ||
| Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastroint | Q39495232 | ||
| Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials | Q39730010 | ||
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial | Q39748379 | ||
| Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials | Q44748843 | ||
| Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer | Q46453563 | ||
| Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc | Q46974069 | ||
| Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. | Q54493989 | ||
| P433 | issue | 1 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 160-165 | |
| P577 | publication date | 2012-08-16 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study | |
| P478 | volume | 24 |
| Q34995307 | A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer |
| Q38272671 | A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer |
| Q33698724 | Adjuvant chemotherapy |
| Q87833376 | Adjuvant chemotherapy for rectal cancer |
| Q38963455 | Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis. |
| Q33417569 | Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial |
| Q36303226 | Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate |
| Q38322257 | Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? |
| Q60923165 | Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study |
| Q28084403 | Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease |
| Q41737184 | The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer |
| Q55019425 | Tumor location is an independent predictive factor for distant metastasis and metastatic sites of rectal adenocarcinoma in patients receiving total mesorectal excision. |
Search more.